Liberating Technologies

Liberating Technologies, Inc., commonly known as LTI, is a research and development company based in Holliston, Massachusetts. The company is associated with the development of assistive and prosthetic technologies, particularly electronic upper-limb prostheses. Its work has been supported through research funding from United States government and public-sector institutions, including the Department of Defense, the National Institutes of Health, and the Department of Veterans Affairs, as well as other organizations. LTI is best known for the Boston Digital Arm, a prosthetic hand recognized for incorporating a microcontroller into the hand system. The device represents an important stage in the development of electronically controlled upper-limb prostheses, combining mechanical components with embedded control technology. This work placed LTI within the broader field of rehabilitation engineering, where research focuses on restoring or augmenting physical function through engineered devices. The company operates primarily as a research and development organization rather than as a widely distributed consumer brand. Its activities have centered on applied engineering, prosthetics research, and technology development for users with limb loss or limb impairment. The available reference material does not provide a founding year, founder, detailed product portfolio, financial information, or a full account of the company's commercial operations. In 2021, Liberating Technologies was purchased by Coapt, LLC, a company known for myoelectric pattern-recognition technology. The acquisition connected LTI's prosthetics research and development capabilities with Coapt's expertise in interpreting muscle signals for powered prosthetic control. LTI remains identified as a company based in Holliston, Massachusetts, and is described as being owned by Coapt.

Liberating Technologies, Inc. is a research and development company headquartered in Holliston, Massachusetts. The available reference material presents the organization primarily through its technical work in prosthetics and rehabilitation engineering rather than through a conventional consumer-brand history. Its research portfolio has received support from the United States Department of Defense, the National Institutes of Health, the Department of Veterans Affairs, and other funding bodies. The company became particularly associated with the Boston Digital Arm, an electronically controlled hand prosthesis. The device is notable for being described as the first hand prosthesis equipped with a microcontroller. The use of embedded computation represented a significant development in prosthetic design, enabling control functions to be handled electronically within the device rather than relying solely on mechanical systems. Through this work, LTI became associated with the transition toward more sophisticated powered and digitally controlled upper-limb prostheses. LTI's activities fit within the field of rehabilitation engineering, which applies engineering research to the needs of people with disabilities and people recovering or adapting to physical impairment. Its government-supported research relationships indicate a focus on applied development and technology transfer, although the available sources do not specify the complete list of projects, contracts, or resulting products. They also do not establish a founding date, original founder, early corporate structure, or detailed chronology of the Boston Digital Arm's development. A major corporate turning point occurred in 2021, when Coapt, LLC purchased Liberating Technologies. Coapt is known for myoelectric pattern recognition, a technology area involving the interpretation of muscle signals to control powered prosthetic devices. The acquisition brought LTI under Coapt ownership and linked LTI's prosthetic research and development background with Coapt's expertise in myoelectric control. The available material does not disclose the transaction's financial terms, operational changes, executive appointments, or product-retirement decisions. Following the acquisition, Liberating Technologies continued to be described as a Holliston-based company owned by Coapt. Publicly available reference material remains limited regarding its current product catalog, workforce, sales channels, international activity, and standalone brand strategy. Its documented identity is therefore best understood as that of a specialized prosthetics and rehabilitation-technology R&D organization operating within Coapt's ownership structure.

• 2021

  Acquisition by Coapt

  [1]Liberating Technologiesen.wikipedia.org

  Coapt, LLC purchased Liberating Technologies, bringing the Massachusetts-based prosthetics research company under Coapt ownership.

Research-led rehabilitation engineering company focused on advanced prosthetic and assistive technologies, with particular expertise in electronically controlled upper-limb systems.

• Upper-limb prosthesis

  Boston Digital Arm

  The Boston Digital Arm is an electronically controlled hand prosthesis associated with Liberating Technologies. It is noted for being the first hand prosthesis equipped with a microcontroller, marking an important step in the use of embedded digital control in upper-limb prosthetic devices. The available reference material does not provide detailed specifications, launch information, current availability, or distribution details.

• 2021

  Coapt acquisitionM&A

  Background

  Liberating Technologies operated as a specialized prosthetics and rehabilitation-technology research and development company, while Coapt was known for myoelectric pattern-recognition technology.

  Action taken

  Coapt, LLC purchased Liberating Technologies.

  Aftermath

  Liberating Technologies became owned by Coapt. The available source does not describe financial terms, organizational integration, executive changes, or specific product consequences.

  Source

1. 1Liberating Technologiesen.wikipedia.org